Ashley Cordova - 02 Aug 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Chief Financial Officer
Signature
By: /s/ Steven Robbins, Attorney in Fact for Ashley Cordova
Issuer symbol
NVCR
Transactions as of
02 Aug 2022
Net transactions value
+$499,964
Form type
4
Filing time
03 Aug 2022, 16:45:16 UTC
Previous filing
07 Jul 2022
Next filing
06 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Ordinary Shares Award $499,964 +7,122 +11% $70.20 73,261 02 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted share units that are scheduled to vest in equal installments on each of August 2, 2023, 2024 and 2025, subject to the reporting person's continued employment through such dates.